Following the news that Chinese regulators fined foreign manufacturers of infant milk formula $110 million on allegations of price-fixing, the National Development and Reform Commission is reportedly threatening to issue stricter fines in the future. Six companies, including Mead Johnson, were hit with the fines after a four-month probe. China announced the fines on Wednesday. Just one day later, the NDRC said such practices will earn stricter fines: “If we discover firms knowingly breaking the law,” said NDRC head Xu Kunlin, “then fines will be increasingly severe. National media reported the milk formula fines set a record for China; all six companies said they would not contest the fines. The NDRC is currently probing the nation’s pharmaceutical industry, eying 60 companies, both foreign and domestic.
Featured News
O’Melveny Adds Two Prominent Antitrust Litigators in San Francisco and Washington
Mar 2, 2026 by
CPI
Trial Examines Elon Musk’s 2022 Attempt to Abandon Twitter Deal
Mar 2, 2026 by
CPI
Supreme Court Declines to Weigh In on Copyright Protection for AI-Generated Art
Mar 2, 2026 by
CPI
German Antitrust Authority Clears Strabag’s Stumpp Takeover with Required Plant Sale
Mar 2, 2026 by
CPI
Sony Faces £2 Billion UK Lawsuit Over PlayStation Store Pricing
Mar 2, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece